roundhill glp-1 & weight loss etf Your portfolio could start gaining… in a good way. Let's talk about the $OZEM: https://t.co/dTPG0sY0Sb 다이어트약 붐은 ETF로도 이어진다!(feat. 라운드힐의

V., Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations, BMC Med, vol

However, the retrospective design carries inherent limitations

Positive trial data led to approval for use as an obesity treatment by the U.S

A limitation of the current study is that it was performed using data from a single academic medical center with limited diversity in terms of patient population

This new weight loss drug ETF bets big on two of the industry's leading players While Novo Nordisk and Eli Lilly have soared in the past year, Roundhill Investments sees bigger gains ahead for the GLP-1 drugmakers

Udiawar MV, Bain SC